Hunt highlighted that most of the nearly $11 billion raised in early 2024 went to “later-stage companies” with advanced clinical ... tools to develop diagnostic tests. A key asset in this ...

Quest Diagnostics Inc.’s DGX robust Advanced Diagnostics offering is poised ... AD-Detect blood-based Alzheimer’s disease testing has been the key driver, while growth in women’s health ...

Atomo Diagnostics Ltd. (AU:AT1) has released an update. Atomo Diagnostics Ltd. recently held its 2024 Annual General Meeting where all resolutions were conducted via a poll, resulting in the ...

With these advanced technologies, we equip businesses across various industries to achieve faster, data-backed decisions, fostering greater agility, operational efficiency, and a distinct competitive ...

Expansion efforts have increased its customer base and access to complex diagnostics fields such as molecular testing and oncology. Quest has been focusing on advanced diagnostics and enhancing ...

Quest Diagnostics Inc (NYSE:DGX) saw double-digit revenue growth in advanced diagnostics, particularly in brain health, women's health, cardiometabolic health, and autoimmune disorders.

We enable growth across our customer channels through advanced ... for diagnostic information services were up 9% compared to the prior year, reflecting strong growth in our key physician and ...

The Indian Institute of Technology (IIT) Kanpur has announced the eligibility criteria for JEE Advanced 2025, the prestigious entrance exam for admission to undergraduate engineering programs at IITs.

BCAL Diagnostics Limited (AU:BDX) has released an update. BCAL Diagnostics Limited is set to hold its Annual General Meeting on November 22, 2024, where shareholders will review financial reports ...

Advanced Micro Devices AMD-2.84%decrease; red down pointing triangle is reducing its global workforce by 4% after reporting that most of the growth it sees comes from its AI chips and other ...